According to new reports, Chris Bosh already wants to play in the 2016-2017 NBA season but it seems he's having problems convincing the Miami Heat. In fact, he even tried a new type of medication to help improve his condition.

Bosh was forced to miss the rest of the 2015-2016 season due to his recurring medical condition of blood clotting. Because of this, he resorted to taking blood thinners to help alleviate his condition.

The problem with this treatment method, however, is that it has adverse effects that could lead to bleeding complications. Which is why even though he's ready to play during the latter half of last season, the Heat organization kept him off the court to prevent endangering his health even further, according to Miami Herald.

Due to its effects, Bosh has reportedly switched to a new and safer form of treatment. He also allegedly tried to convince the team to let him play since the new type of thinners will be out of his body's system within eight to 12 hours. However, the team once again denied his request and prevented him from playing.

A health expert weighed in on Bosh's case and noted that he's a bit skeptical of the effectivity of the new medication.

"Someone who has had a second clot is more likely to have another, but the specific circumstances of an athlete might be different," Robert Myerburg of UHealth said. "If you take the total population of people who have had this thing, once you had a second, you're at risk for a third."

"But that doesn't get into the issue of how a subgroup [such as pro athletes] may behave because of things that make them more prone for blood clots," he added.

According to the site, this ruling angered Bosh and maintains that he should be given the clearance to play. It is not yet clear if the team will reconsider Bosh's request to play but if it doesn't, then the athlete might resort to taking the matter to the players' unions, which could lead to bigger problems for the Heat.